Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.

A man had both alopecia areata and lichen planus, which is uncommon.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Effective treatments for severe alopecia areata are still lacking.

CD2 might be a new treatment target for patchy alopecia areata.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

A mother and son both had ulcerative colitis and alopecia, suggesting a genetic link in autoimmune disorders and successful treatment with cyclosporine.

People with alopecia areata often have lower vitamin D levels and more inflammation, suggesting vitamin D might be involved in the condition.

Contact sensitizers like DCP and SADBE are the most effective treatments for alopecia areata.

Childhood Alopecia Areata causes hair loss and requires varied treatments, with psychological support being crucial.

Allergic reactions to blood thinners are rare but can be serious, requiring careful management and alternative treatments.

Two siblings had a rare immune disorder caused by a FOXN1 gene mutation.

A protein combining parathyroid hormone and collagen helped hair regrow in mice with a hair loss condition.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

The document discusses various diseases of the outer ear, categorized by symptoms like redness, crusts, bumps, pus-filled lesions, lumps, ulcers, and hair loss.

Sulforaphane from broccoli may help treat certain cancers, hormone issues, and hair loss.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

The document concludes that scalp health is influenced by complex factors affecting sebaceous glands, including hormones, aging, and various substances.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

Topical PUVA can cause temporary hair regrowth in some alopecia areata patients but doesn't change the long-term outcome.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.